Signal2026-08-03
ClinicalTrials.gov

[PHASE2] Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Part of

Emerging Cancer Biomarker Techniques

Open primary sourceSee the whole picture